EUVIMEDEUVIMED entdecken
Crossref

Personalized Vascularized Tumor Organoid‐on‐a‐Chip for Tumor Metastasis and Therapeutic Targeting Assessment

Yang Du, Yi-Ran Wang, Qi-Yuan Bao, Xin-Xin Xu, Congling Xu, Shaoxuan Wang, Qi Liu, Fan Liu, Yu-Lian Zeng, Ya-Jun Wang, Wei Liu, Yixin Liu und 11 weitere

Advanced Materials · 2025-02 · 37 (6)

DOI: 10.1002/adma.202412815 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 26.12.2024. Verfasst von Yang Du und 22 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Xuhui Central Hospital, Zhongshan-Xuhui Hospital, Shanghai Key Laboratory of Medical Epigenetics, Institutes of Biomedical Sciences, Departm…. Hauptthemen laut MEDLINE: Organoids, Neovascularization, Pathologic, Precision Medicine, Lab-On-A-Chip Devices. Die Arbeit wurde bisher 97-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: National Natural Science Foundation of China, International Human Frontier Science Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While tumor organoids have revolutionized cancer research by recapitulating the cellular architecture and behaviors of real tumors in vitro, their lack of functional vasculature hinders their attainment of full physiological capabilities. Current efforts to vascularize organoids are struggling to achieve well‐defined vascular networks, mimicking the intricate hierarchy observed in vivo, which restricts the physiological relevance particularly for studying tumor progression and response to therapies targeting the tumor vasculature. An innovative vascularized patient‐derived tumor organoids (PDTOs)‐on‐a‐chip with hierarchical, tumor‐specific microvasculature is presented, providing a versatile platform to explore tumor‐vascular dynamics and antivascular drug efficacy. It is found that highly metastatic tumor cells induced vessel angiogenesis and simultaneously migrated toward blood vessels via the Notch pathway. The evident association between the angiogenic and migratory capacities of PDTOs and their clinical metastatic outcomes underscores the potential of the innovative platform for evaluating tumor metastasis, thus offering valuable insights for clinical decision‐making. Ultimately, the system represents a promising avenue for advancing the understanding of tumor metastasis and developing personalized treatment strategies based on patient‐specific tumor characteristics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrganoidsNeovascularization, PathologicPrecision MedicineLab-On-A-Chip DevicesNeoplasmsHumansNeoplasm MetastasisCell Line, TumorAnimalsCell MovementMice

Stichwörter der Autor:innen

angiogenesismicrofluidicsorganoids‐on‐a‐chiptumor migrationtumor perivascular niche

Autor:innen und Institutionen

  • Shanghai Xuhui Central Hospital, Zhongshan-Xuhui Hospital, Shanghai Key Laboratory of Medical Epigenetics, Institutes of Biomedical Sciences, Department of Chemistry, Fudan University, Shanghai, 200032, China.
  • Department of Orthopaedics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • Shanghai Key Laboratory for Bone and Joint Diseases, Shanghai Institute of Traumatology and Orthopedics, Shanghai, 200025, China.
  • Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation, Clinical Research Center for Anesthesiology and Perioperative Medicine, Shanghai Fourth People's Hospital, School of Life Sciences and Technolog…
  • Fudan University Shanghai Cancer Center, and Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism (Ministry of Science and Technology), Institutes of Biomedic…
  • Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.

ORCID-Profile: Fei Xavier Chen, Yan-Jun Liu

Förderung

  • National Natural Science Foundation of China
  • International Human Frontier Science Program

Zitieren

APA

Du, Y., Wang, Y. R., Bao, Q. Y., Xu, X. X., Xu, C., Wang, S., Liu, Q., Liu, F., Zeng, Y. L., Wang, Y. J., Liu, W., Liu, Y., Yu, S. X., Chen, Y. C., Wang, C., Zhang, W., Gao, H., Luo, H., Liu, B., …, & Liu, Y. J. (2025). Personalized Vascularized Tumor Organoid‐on‐a‐Chip for Tumor Metastasis and Therapeutic Targeting Assessment. Advanced Materials, 37(6). https://doi.org/10.1002/adma.202412815

Vancouver

Du Y, Wang YR, Bao QY, Xu XX, Xu C, Wang S, et al. Personalized Vascularized Tumor Organoid‐on‐a‐Chip for Tumor Metastasis and Therapeutic Targeting Assessment. Advanced Materials. 2025;37(6). doi:10.1002/adma.202412815

BibTeX
@article{Du2025,
  author = {Du, Yang and Wang, Yi-Ran and Bao, Qi-Yuan and Xu, Xin-Xin and Xu, Congling and Wang, Shaoxuan and Liu, Qi and Liu, Fan and Zeng, Yu-Lian and Wang, Ya-Jun and Liu, Wei and Liu, Yixin and Yu, Sai-Xi and Chen, Yu-Chen and Wang, Chen and Zhang, Weibin and Gao, Hai and Luo, Hao and Liu, Baohong and Jing, Guangyin and Guo, Ming and Chen, Fei Xavier and Liu, Yan-Jun},
  title = {Personalized Vascularized Tumor Organoid‐on‐a‐Chip for Tumor Metastasis and Therapeutic Targeting Assessment},
  journal = {Advanced Materials},
  year = {2025},
  volume = {37},
  number = {6},
  doi = {10.1002/adma.202412815}
}
Kostenlos starten →